Metastatic Spinal Tumor Market – Precision Oncology and Advanced Imaging Support Growth
The metastatic spinal tumor market is growing as cancer incidence rises, patient awareness improves, and healthcare providers adopt more advanced diagnostic and therapeutic approaches. The market was valued at USD 1.95 billion in 2024 and is projected to reach USD 3.5 billion by 2035, at a CAGR of 5.4%.wiseguyreports Metastatic spinal tumors can develop when cancer from another site spreads to...
0 Comments 0 Shares 4 Views 0 Reviews